Tips from Other Journals

Three Treatment Regimens for Women with Hirsutism



FREE PREVIEW Log in or buy this issue to read the full article. AAFP members and paid subscribers get free access to all articles. Subscribe now.


FREE PREVIEW Subscribe or buy this issue. AAFP members and paid subscribers get free access to all articles.

Am Fam Physician. 1999 Jun 1;59(11):3160.

Hirsutism results from increased androgen production or excessive androgen activity at the target level. The effect of androgens at the peripheral level depends on the metabolism of testosterone, the ability of free steroid fraction to cross the cell membrane and interaction with intracellular receptors. Pharmacologic treatment focuses on the androgen secretions or the target tissue. Cyproterone acetate has both central and peripheral activity when combined with ethinyl E2. Flutamide and finasteride are two other agents that have been used in the treatment of hirsutism. Fruzzetti and associates studied the safety and efficacy of each of these therapies to determine the best treatment regimen in patients with hirsutism.

The authors recruited 45 women with hirsutism who had no evidence of a secondary cause and had not received any hormonal therapy for six months. The women were randomly assigned to one of three treatment groups. The first treatment regimen was 25 mg of cyproterone acetate per day for the first 10 days of the menstrual cycle along with 20 μg of ethinyl E2 daily for 21 days. The second group received 250 mg of flutamide twice a day, and the third group received 5 mg of finasteride per day. One physician evaluated patients' hirsutism before initiating therapy, and liver function studies were performed to identify hormone levels at baseline and months 3, 6 and 12.

All three therapies significantly reduced hirsutism scores during the study with a similar percent decrease in scores among the groups. No significant side effects were reported in any of the groups, and no one dropped out of the study because of side effects.

Cyproterone acetate with ethinyl E2 has proved to be effective in reducing hirsutism. However, few trials looked at the safety and efficacy of flutamide and finasteride. This study demonstrated that these three agents were equally effective in reducing hirsutism scores, although they have different modes of activity. The authors conclude that all three agents can be used, with minimal side effects, in the treatment of hirsutism.

Fruzzetti F, et al. Treatment of hirsuitism: comparisons between different antiandrogens with central and peripheral effects. Fert Steril. March 1999;71:445–51.


Copyright © 1999 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact afpserv@aafp.org for copyright questions and/or permission requests.

Want to use this article elsewhere? Get Permissions


Article Tools

  • Print page
  • Share this page
  • AFP CME Quiz

Information From Industry

Navigate this Article